recognition determinants broadly neutralizing human antibodies dengue viruses
dengue disease caused four different flavivirus serotypes infect million people yearly % symptomatic cases licensed vaccine available recent phase iii vaccine trials showed partial protection particular protection dengue virus serotype refs structural studies far characterized epitopes recognized serotype-specific human antibodies recently isolated human antibodies potently neutralizing four dengue virus serotypes describe x-ray structures four broadly neutralizing antibodies complex envelope glycoprotein e dengue virus serotype revealing recognition determinants serotype-invariant site e-dimer interface including exposed main chain e fusion loop two conserved glycan chains e-dimer-dependent epitope also binding site viral glycoprotein prm virus maturation secretory pathway infected cell explaining conservation across serotypes highlighting achilles heel virus respect antibody neutralization findings will instrumental devising novel immunogens protect simultaneously four serotypes dengue virus
